249 related articles for article (PubMed ID: 25740823)
21. mTOR Directs Breast Morphogenesis through the PKC-alpha-Rac1 Signaling Axis.
Morrison MM; Young CD; Wang S; Sobolik T; Sanchez VM; Hicks DJ; Cook RS; Brantley-Sieders DM
PLoS Genet; 2015 Jul; 11(7):e1005291. PubMed ID: 26132202
[TBL] [Abstract][Full Text] [Related]
22. Disruption of EphA2 receptor tyrosine kinase leads to increased susceptibility to carcinogenesis in mouse skin.
Guo H; Miao H; Gerber L; Singh J; Denning MF; Gilliam AC; Wang B
Cancer Res; 2006 Jul; 66(14):7050-8. PubMed ID: 16849550
[TBL] [Abstract][Full Text] [Related]
23. Transmembrane Inhibitor of RICTOR/mTORC2 in Hematopoietic Progenitors.
Lee D; Sykes SM; Kalaitzidis D; Lane AA; Kfoury Y; Raaijmakers MH; Wang YH; Armstrong SA; Scadden DT
Stem Cell Reports; 2014 Nov; 3(5):832-40. PubMed ID: 25418727
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of mTOR suppresses UVB-induced keratinocyte proliferation and survival.
Carr TD; DiGiovanni J; Lynch CJ; Shantz LM
Cancer Prev Res (Phila); 2012 Dec; 5(12):1394-404. PubMed ID: 23129577
[TBL] [Abstract][Full Text] [Related]
25. High prevalence of mTOR complex activity can be targeted using Torin2 in papillary thyroid carcinoma.
Ahmed M; Hussain AR; Bavi P; Ahmed SO; Al Sobhi SS; Al-Dayel F; Uddin S; Al-Kuraya KS
Carcinogenesis; 2014 Jul; 35(7):1564-72. PubMed ID: 24583924
[TBL] [Abstract][Full Text] [Related]
26. Rictor/mTORC2 deficiency enhances keratinocyte stress tolerance via mitohormesis.
Tassone B; Saoncella S; Neri F; Ala U; Brusa D; Magnuson MA; Provero P; Oliviero S; Riganti C; Calautti E
Cell Death Differ; 2017 Apr; 24(4):731-746. PubMed ID: 28211872
[TBL] [Abstract][Full Text] [Related]
27. microRNA-153 Targets mTORC2 Component Rictor to Inhibit Glioma Cells.
Cui Y; Zhao J; Yi L; Jiang Y
PLoS One; 2016; 11(6):e0156915. PubMed ID: 27295037
[TBL] [Abstract][Full Text] [Related]
28. Raised expression of the antiapoptotic protein ped/pea-15 increases susceptibility to chemically induced skin tumor development.
Formisano P; Perruolo G; Libertini S; Santopietro S; Troncone G; Raciti GA; Oriente F; Portella G; Miele C; Beguinot F
Oncogene; 2005 Oct; 24(47):7012-21. PubMed ID: 16044159
[TBL] [Abstract][Full Text] [Related]
29. Deregulated minichromosomal maintenance protein MCM7 contributes to oncogene driven tumorigenesis.
Honeycutt KA; Chen Z; Koster MI; Miers M; Nuchtern J; Hicks J; Roop DR; Shohet JM
Oncogene; 2006 Jul; 25(29):4027-32. PubMed ID: 16518415
[TBL] [Abstract][Full Text] [Related]
30. Stage-specific disruption of Stat3 demonstrates a direct requirement during both the initiation and promotion stages of mouse skin tumorigenesis.
Kataoka K; Kim DJ; Carbajal S; Clifford JL; DiGiovanni J
Carcinogenesis; 2008 Jun; 29(6):1108-14. PubMed ID: 18453544
[TBL] [Abstract][Full Text] [Related]
31. The effect of PPARgamma ligands on UV- or chemically-induced carcinogenesis in mouse skin.
He G; Muga S; Thuillier P; Lubet RA; Fischer SM
Mol Carcinog; 2005 Aug; 43(4):198-206. PubMed ID: 15864802
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of PRAS40(T246A) in the Proliferative Compartment Suppresses mTORC1 Signaling, Keratinocyte Migration, and Skin Tumor Development.
Rho O; Srivastava J; Cho J; DiGiovanni J
J Invest Dermatol; 2016 Oct; 136(10):2070-2079. PubMed ID: 27349859
[TBL] [Abstract][Full Text] [Related]
33. Lack of expression of the EP2 but not EP3 receptor for prostaglandin E2 results in suppression of skin tumor development.
Sung YM; He G; Fischer SM
Cancer Res; 2005 Oct; 65(20):9304-11. PubMed ID: 16230392
[TBL] [Abstract][Full Text] [Related]
34. Conditional ablation of C/EBP beta demonstrates its keratinocyte-specific requirement for cell survival and mouse skin tumorigenesis.
Sterneck E; Zhu S; Ramirez A; Jorcano JL; Smart RC
Oncogene; 2006 Feb; 25(8):1272-1276. PubMed ID: 16205634
[TBL] [Abstract][Full Text] [Related]
35. Involvement of retrotransposition of long interspersed nucleotide element-1 in skin tumorigenesis induced by 7,12-dimethylbenz[a]anthracene and 12-O-tetradecanoylphorbol-13-acetate.
Okudaira N; Goto M; Yanobu-Takanashi R; Tamura M; An A; Abe Y; Kano S; Hagiwara S; Ishizaka Y; Okamura T
Cancer Sci; 2011 Nov; 102(11):2000-6. PubMed ID: 21827582
[TBL] [Abstract][Full Text] [Related]
36. Lycopene Protects Keratinocytes Against UVB Radiation-Induced Carcinogenesis via Negative Regulation of FOXO3a Through the mTORC2/AKT Signaling Pathway.
Chen P; Xu S; Qu J
J Cell Biochem; 2018 Jan; 119(1):366-377. PubMed ID: 28585698
[TBL] [Abstract][Full Text] [Related]
37. Distinct signaling mechanisms of mTORC1 and mTORC2 in glioblastoma multiforme: a tale of two complexes.
Jhanwar-Uniyal M; Gillick JL; Neil J; Tobias M; Thwing ZE; Murali R
Adv Biol Regul; 2015 Jan; 57():64-74. PubMed ID: 25442674
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the in vivo safety profiles of Rictor inhibition using a zebrafish model.
Cao Y; Jiang L; Zhao L; Zhou X; Wang N; Zhang P; Tang Y; Zhou J
Curr Pharm Des; 2015; 21(12):1645-53. PubMed ID: 25557637
[TBL] [Abstract][Full Text] [Related]
39. Tetraspanin 8-rictor-integrin α3 complex is required for glioma cell migration.
Pan SJ; Zhan SK; Pan YX; Liu W; Bian LG; Sun B; Sun QF
Int J Mol Sci; 2015 Mar; 16(3):5363-74. PubMed ID: 25761241
[TBL] [Abstract][Full Text] [Related]
40. Forced expression of a constitutively active form of Stat3 in mouse epidermis enhances malignant progression of skin tumors induced by two-stage carcinogenesis.
Chan KS; Sano S; Kataoka K; Abel E; Carbajal S; Beltran L; Clifford J; Peavey M; Shen J; Digiovanni J
Oncogene; 2008 Feb; 27(8):1087-94. PubMed ID: 17700521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
